Ancora Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-109
Closed -$11.1K 2448
2025
Q4
$11.1K Buy
+109
New +$8.75K ﹤0.01% 1769
2023
Q4
Sell
-325
Closed -$22.2K 1781
2023
Q3
$22.2K Hold
325
﹤0.01% 1123
2023
Q2
$30.5K Hold
325
﹤0.01% 1032
2023
Q1
$22K Sell
325
-9
-3% -$578 ﹤0.01% 1107
2022
Q4
$16K Sell
334
-191
-36% -$7.8K ﹤0.01% 1237
2022
Q3
$17K Hold
525
﹤0.01% 1376
2022
Q2
$21K Hold
525
﹤0.01% 1418
2022
Q1
$37K Hold
525
﹤0.01% 1364
2021
Q4
$41K Hold
525
﹤0.01% 1351
2021
Q3
$50K Buy
525
+200
+62% +$21.1K ﹤0.01% 1187
2021
Q2
$40K Hold
325
﹤0.01% 1166
2021
Q1
$43K Hold
325
﹤0.01% 1114
2020
Q4
$43K Hold
325
﹤0.01% 913
2020
Q3
$33K Hold
325
﹤0.01% 932
2020
Q2
$28K Sell
325
-253
-44% -$20.2K ﹤0.01% 932
2020
Q1
$34K Buy
+578
New +$46.9K ﹤0.01% 957

Other funds holding EXAS

Ancora Advisors's EXAS Position: Q1 2026 in Review

Ancora Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 109 shares — an estimated $11.1K sold.

Ancora Advisors first reported a position in EXAS in Q1 2020 and held it in 16 quarters. The position peaked at $50K in Q3 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Ancora Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Ancora Advisors sold 109 Exact Sciences shares in Q1 2026, an estimated $11.1K.
  • Ancora Advisors first reported a position in Exact Sciences in Q1 2020 and held it in 16 quarters.
  • Ancora Advisors's Exact Sciences position peaked at $50K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.